A Phase I/II Study of Rituximab Plus Vincristine Sulfate Liposomes Injection in the Treatment of Relapsed or Refractory Aggressive Non Hodgkin's Lymphoma
Latest Information Update: 07 Oct 2022
At a glance
- Drugs Vincristine (Primary) ; Rituximab
- Indications Diffuse large B cell lymphoma; Mantle-cell lymphoma; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- Sponsors Spectrum Pharmaceuticals
- 14 May 2013 New trial record